Not Yet Recruiting
An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH
NCT07528235
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- Department of Neurosurgery , Tangdu Hospital, Fourth Military Medical University Xi'an, Shaanxi, China